Civic Intelligence

International Lymphoma Radiation

EIN 46-1995761 • 501(c)3 • Orient, NY

Profile

The mission of ilrog is to improve the outcome for patients by encouraging the appropriate integration of radiation therapy in the management of lymphoma. Ilrog objectives: - to optimize, advance and harmonize the integration of radiation therapy in the management of lymphoma patients. - to inform the hematology, medical and radiation oncology communities of the lymphoma scenarios where appropriate utilization of radiotherapy is advantageous. - to develop and disseminate evidence-based guidelines for radiotherapy fields, doses and techniques for all types of lymphomas. - to train radiation oncologists worldwide in using modern lymphoma radiotherapy principles and techniques via collaboration with appropriate national or regional scientific societies. - to provide a worldwide forum for radiation oncologists who treat lymphomas to discuss and share information and ideas. - to provide a source of information for lymphoma patients explaining the advantages and risks associated with radiati

965 Edwards LaneOrient, NY 11957-1031

www.ilrog.com

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

Score unavailable

No value available

Liabilities-to-assets requires both liabilities and assets on the latest valid filing.

Source year 2024

Liabilities / Revenue

Score unavailable

No value available

Liabilities-to-revenue requires both liabilities and revenue on the latest valid filing.

Source year 2024

Net Margin

59th percentile

14%

Higher net margin than 59% of similar nonprofits.

NTEE E70 • <$500k nonprofits • Source year 2024

Top Officer Pay

79th percentile

$0

Higher top officer pay than 79% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

NTEE E70 • <$500k nonprofits • Source year 2024

Asset Growth

61st percentile

7.7%

Faster asset growth than 61% of similar nonprofits.

NTEE E70 • <$500k nonprofits • Annualized from 2023 to 2024

Revenue Growth

48th percentile

0.5%

Faster revenue growth than 48% of similar nonprofits.

NTEE E70 • <$500k nonprofits • Annualized from 2023 to 2024

Assets

Up

$166,978

Up $12,007 (+7.7%) from 2023

Liabilities

-

No earlier filing loaded for comparison.

Net Assets

Up

$166,978

Up $12,007 (+7.7%) from 2023

Revenue

Up

$84,748

Up $436 (+0.5%) from 2023

Expenses

Down

$72,740

Down $4,259 (-5.5%) from 2023

Net Income

Up

$12,008

Up $4,695 (+64%) from 2023

Trend Graphs

Balance Sheet Trend

Grouped bars show assets, liabilities, and net assets across loaded filings.

$200K$150K$100K$50K$0Assets 2013: $46,109Liabilities 2013: $02013Assets 2014: $58,418Liabilities 2014: $02014Assets 2015: $116,551Net Assets 2015: $116,5512015Assets 2016: $115,139Net Assets 2016: $115,1392016Assets 2017: $126,527Net Assets 2017: $126,5272017Assets 2018: $132,155Net Assets 2018: $132,1552018Assets 2019: $136,737Net Assets 2019: $136,7372019Assets 2020: $162,615Net Assets 2020: $162,6152020Assets 2021: $156,596Net Assets 2021: $156,5962021Assets 2023: $154,971Net Assets 2023: $154,9712023Assets 2024: $166,978Net Assets 2024: $166,9782024

Highlighted filing

2024

Assets$166,978
Liabilities-
Net Assets$166,978

Operations Trend

Revenue, expenses, and net income by year, with the latest filing highlighted.

$150K$100K$50K$0-$50KRevenue 2013: $84,000Expenses 2013: $37,891Net Income 2013: $46,1092013Revenue 2014: $52,146Expenses 2014: $39,837Net Income 2014: $12,3092014Revenue 2015: $131,807Expenses 2015: $73,674Net Income 2015: $58,1332015Revenue 2016: $63,094Expenses 2016: $64,506Net Income 2016: -$1,4122016Revenue 2017: $86,626Expenses 2017: $75,238Net Income 2017: $11,3882017Revenue 2018: $84,485Expenses 2018: $78,857Net Income 2018: $5,6282018Revenue 2019: $34,698Expenses 2019: $30,115Net Income 2019: $4,5832019Revenue 2020: $52,029Expenses 2020: $26,150Net Income 2020: $25,8792020Revenue 2021: $31,583Expenses 2021: $37,602Net Income 2021: -$6,0192021Revenue 2023: $84,312Expenses 2023: $76,999Net Income 2023: $7,3132023Revenue 2024: $84,748Expenses 2024: $72,740Net Income 2024: $12,0082024

Highlighted filing

2024

Revenue$84,748
Expenses$72,740
Net Income$12,008

Filings

Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2024 to Dec 31, 2024
Signed
Oct 31, 2025
Return Version
2024v5.0
Gross Receipts
$84,748
Mission and Program Overview

Mission

The mission of ilrog is to improve the outcome for patients by encouraging the appropriate integration of radiation therapy in the management of lymphoma. Ilrog objectives: - to optimize, advance and harmonize the integration of radiation therapy in the management of lymphoma patients. - to inform the hematology, medical and radiation oncology communities of the lymphoma scenarios where appropriate utilization of radiotherapy is advantageous. - to develop and disseminate evidence-based guidelines for radiotherapy fields, doses and techniques for all types of lymphomas. - to train radiation oncologists worldwide in using modern lymphoma radiotherapy principles and techniques via collaboration with appropriate national or regional scientific societies. - to provide a worldwide forum for radiation oncologists who treat lymphomas to discuss and share information and ideas. - to provide a source of information for lymphoma patients explaining the advantages and risks associated with radiati

Program Services

DescriptionGrantsExpenses
2024 ACCOMPLISHMENTS INCLUDE CONTINUED EDUCATION OF MEMBERSHIP BY CREATING, PUBLISHING AND CREATING GUIDELINES. MULTICENTER COLLABORATION ON RESEARCH PROJECTS. AN INTERNATIONAL CONFERENCE WAS HELD IN BEIJING, CHINA.-$68,780
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
JOACHIM YAHALOM MDChairmanPT$0--
LENA SPECHT MDVice-ChairmaPT$0--
TIM ILLIDGE MDSecretary/TrPT$0--
Filing and Contact Details

Filer

Filer Name
International Lymphoma Radiation
EIN
46-1995761
Phone
2126395999
Address
965 EDWARDS LANE, ORIENT, NY 11957-1031

Signing Officer

Name
Joachim Yahalom Md
Title
Chairman
Phone
2126395999
Signed
2025-10-31
Discuss with paid preparer
Yes

Preparer

Firm
COMER & COMPANY CPA'S LLC
Address
61 MAIN STREET, MIDDLETOWN, CT 06457-3408
Preparer
Thomas D Comer CPA
Phone
8603462100
Supplemental Narrative

Additional Explanations

Form 990-ez, Part I, Line 16

Expenses office expenses 120 website/hosting 1,191 technology expenses 6,084 conferences & meetings 10,046 bank fees 1,990 payroll processing fees 913 dues & subscriptions 637 awards and host gifts 2,182 total 23,163

Form 990-ez, Part III

The mission of ilrog is to improve the outcome for patients by encouraging the appropriate integration of radiation therapy in the management of lymphoma. Ilrog objectives: - to optimize, advance and harmonize the integration of radiation therapy in the management of lymphoma patients. - to inform the hematology, medical and radiation oncology communities of the lymphoma scenarios where appropriate utilization of radiotherapy is advantageous. - to develop and disseminate evidence-based guidelines for radiotherapy fields, doses and techniques for all types of lymphomas. - to train radiation oncologists worldwide in using modern lymphoma radiotherapy principles and techniques via collaboration with appropriate national or regional scientific societies. - to provide a worldwide forum for radiation oncologists who treat lymphomas to discuss and share information and ideas. - to provide a source of information for lymphoma patients explaining the advantages and risks associated with radiation therapy. - to initiate, support and conduct research that will further the understanding of radiotherapy in the treatment of lymphoma and that will improve the therapeutic ratio of using radiotherapy alone or in combination with other therapies.

Raw XML Appendix149 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0INTERNATIONAL LYMPHOMA RADIATION
IRS990EZ/BooksInCareOfDetail/BusinessName/BusinessNameLine2Txt0INTERNATIONAL LYMPHOMA RADIATION
IRS990EZ/BooksInCareOfDetail/PhoneNum02126395999
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt0351 E 51ST ST APT 14C
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine2Txt035 E 51ST ST APT 14C
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0NEW YORK
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0NY
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd010022
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt0154970
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt0166978
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/ContributionsGiftsGrantsEtcAmt040000
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt012008
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt0420
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt0154970
IRS990EZ/Form990TotalAssetsGrp/EOYAmt0166978
IRS990EZ/GrossReceiptsAmt084748
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InvestmentIncomeAmt0153
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0false
IRS990EZ/MembershipDuesAmt044595
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt0154970
IRS990EZ/NetAssetsOrFundBalancesEOYAmt0166978
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt0154970
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt0166978
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt012.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt18.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt28.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0JOACHIM YAHALOM MD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1LENA SPECHT MD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2TIM ILLIDGE MD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0CHAIRMAN
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1VICE-CHAIRMA
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2SECRETARY/TR
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherExpensesTotalAmt023163
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0THE MISSION OF ILROG IS TO IMPROVE THE OUTCOME FOR PATIENTS BY ENCOURAGING THE APPROPRIATE INTEGRATION OF RADIATION THERAPY IN THE MANAGEMENT OF LYMPHOMA. ILROG OBJECTIVES: - TO OPTIMIZE, ADVANCE AND HARMONIZE THE INTEGRATION OF RADIATION THERAPY IN THE MANAGEMENT OF LYMPHOMA PATIENTS. - TO INFORM THE HEMATOLOGY, MEDICAL AND RADIATION ONCOLOGY COMMUNITIES OF THE LYMPHOMA SCENARIOS WHERE APPROPRIATE UTILIZATION OF RADIOTHERAPY IS ADVANTAGEOUS. - TO DEVELOP AND DISSEMINATE EVIDENCE-BASED GUIDELINES FOR RADIOTHERAPY FIELDS, DOSES AND TECHNIQUES FOR ALL TYPES OF LYMPHOMAS. - TO TRAIN RADIATION ONCOLOGISTS WORLDWIDE IN USING MODERN LYMPHOMA RADIOTHERAPY PRINCIPLES AND TECHNIQUES VIA COLLABORATION WITH APPROPRIATE NATIONAL OR REGIONAL SCIENTIFIC SOCIETIES. - TO PROVIDE A WORLDWIDE FORUM FOR RADIATION ONCOLOGISTS WHO TREAT LYMPHOMAS TO DISCUSS AND SHARE INFORMATION AND IDEAS. - TO PROVIDE A SOURCE OF INFORMATION FOR LYMPHOMA PATIENTS EXPLAINING THE ADVANTAGES AND RISKS ASSOCIATED WITH RADIATI
IRS990EZ/PrintingPublicationsPostageAmt0603
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt02024 ACCOMPLISHMENTS INCLUDE CONTINUED EDUCATION OF MEMBERSHIP BY CREATING, PUBLISHING AND CREATING GUIDELINES. MULTICENTER COLLABORATION ON RESEARCH PROJECTS. AN INTERNATIONAL CONFERENCE WAS HELD IN BEIJING, CHINA.
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt068780
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/SalariesOtherCompEmplBnftAmt048554
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TotalExpensesAmt072740
IRS990EZ/TotalProgramServiceExpensesAmt068780
IRS990EZ/TotalRevenueAmt084748
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0WWW.ILROG.COM
IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt0RESEARCH 40,000
IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc0SUPPORTING SCHEDULE
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt044595
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt044185
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt035058
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt031583
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus4YearsAmt052029
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt0207450
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearAmt0153
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus1YearAmt0127
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus4YearsAmt0184
IRS990ScheduleA/GrossInvestmentIncome509Grp/TotalAmt0464
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearAmt0153
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus1YearAmt0127
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus4YearsAmt0184
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/TotalAmt0464
IRS990ScheduleA/InvestmentIncomeCYPct00.00000
IRS990ScheduleA/InvestmentIncomePYPct00.00000
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct00.99780
IRS990ScheduleA/PublicSupportPY509Pct00.99620
IRS990ScheduleA/PublicSupportTotal509Amt0207450
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt044595
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt044185
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt035058
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt031583
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt052029
IRS990ScheduleA/Total509Grp/TotalAmt0207450
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt044748
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt044312
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt035058
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt031583
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt052213
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt0207914
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0EXPENSES OFFICE EXPENSES 120 WEBSITE/HOSTING 1,191 TECHNOLOGY EXPENSES 6,084 CONFERENCES & MEETINGS 10,046 BANK FEES 1,990 PAYROLL PROCESSING FEES 913 DUES & SUBSCRIPTIONS 637 AWARDS AND HOST GIFTS 2,182 TOTAL 23,163
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1THE MISSION OF ILROG IS TO IMPROVE THE OUTCOME FOR PATIENTS BY ENCOURAGING THE APPROPRIATE INTEGRATION OF RADIATION THERAPY IN THE MANAGEMENT OF LYMPHOMA. ILROG OBJECTIVES: - TO OPTIMIZE, ADVANCE AND HARMONIZE THE INTEGRATION OF RADIATION THERAPY IN THE MANAGEMENT OF LYMPHOMA PATIENTS. - TO INFORM THE HEMATOLOGY, MEDICAL AND RADIATION ONCOLOGY COMMUNITIES OF THE LYMPHOMA SCENARIOS WHERE APPROPRIATE UTILIZATION OF RADIOTHERAPY IS ADVANTAGEOUS. - TO DEVELOP AND DISSEMINATE EVIDENCE-BASED GUIDELINES FOR RADIOTHERAPY FIELDS, DOSES AND TECHNIQUES FOR ALL TYPES OF LYMPHOMAS. - TO TRAIN RADIATION ONCOLOGISTS WORLDWIDE IN USING MODERN LYMPHOMA RADIOTHERAPY PRINCIPLES AND TECHNIQUES VIA COLLABORATION WITH APPROPRIATE NATIONAL OR REGIONAL SCIENTIFIC SOCIETIES. - TO PROVIDE A WORLDWIDE FORUM FOR RADIATION ONCOLOGISTS WHO TREAT LYMPHOMAS TO DISCUSS AND SHARE INFORMATION AND IDEAS. - TO PROVIDE A SOURCE OF INFORMATION FOR LYMPHOMA PATIENTS EXPLAINING THE ADVANTAGES AND RISKS ASSOCIATED WITH RADIATION THERAPY. - TO INITIATE, SUPPORT AND CONDUCT RESEARCH THAT WILL FURTHER THE UNDERSTANDING OF RADIOTHERAPY IN THE TREATMENT OF LYMPHOMA AND THAT WILL IMPROVE THE THERAPEUTIC RATIO OF USING RADIOTHERAPY ALONE OR IN COMBINATION WITH OTHER THERAPIES.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990-EZ, PART I, LINE 16
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990-EZ, PART III
ReturnHeader/BuildTS02025-03-06 01:10:19Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0JOACHIM YAHALOM MD
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0CHAIRMAN
ReturnHeader/BusinessOfficerGrp/PhoneNum02126395999
ReturnHeader/BusinessOfficerGrp/SignatureDt02025-10-31
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0INTERNATIONAL LYMPHOMA RADIATION
ReturnHeader/Filer/BusinessName/BusinessNameLine2Txt0ONCOLOGY FOUNDATION
ReturnHeader/Filer/BusinessNameControlTxt0INTE
ReturnHeader/Filer/EIN0461995761
ReturnHeader/Filer/PhoneNum02126395999
ReturnHeader/Filer/USAddress/AddressLine1Txt0965 EDWARDS LANE
ReturnHeader/Filer/USAddress/CityNm0ORIENT
ReturnHeader/Filer/USAddress/StateAbbreviationCd0NY
ReturnHeader/Filer/USAddress/ZIPCd0119571031
ReturnHeader/IRSResponsiblePrtyInfoCurrInd0false
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0522436535
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0COMER & COMPANY CPA'S LLC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt061 MAIN STREET
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0MIDDLETOWN
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0CT
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd0064573408
ReturnHeader/PreparerPersonGrp/PhoneNum08603462100
ReturnHeader/PreparerPersonGrp/PreparationDt02025-10-31
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0THOMAS D COMER CPA
ReturnHeader/ReturnTs02025-11-12T13:54:36-05:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02024-01-01
ReturnHeader/TaxPeriodEndDt02024-12-31
ReturnHeader/TaxYr02024

Document Assets

No mirrored PDF or thumbnail assets are attached yet.